Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 May;36(5):749–754. doi: 10.1136/gut.36.5.749

Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection.

M Lenzi 1, P Manotti 1, L Muratori 1, M Cataleta 1, G Ballardini 1, F Cassani 1, F B Bianchi 1
PMCID: PMC1382681  PMID: 7797126

Abstract

Within the multiform liver/kidney microsomal (LKM) family, a subgroup of sera that reacts with a liver cytosolic (LC) protein has been isolated and the new antigen-antibody system is called LC1. Unlike LKM antibody type 1 (anti-LKM1), anti-LC1 is said to be unrelated to hepatitis C virus (HCV) infection and has therefore been proposed as a marker of 'true' autoimmune hepatitis type 2. Altogether 100 LKM1 positive sera were tested by immunodiffusion (ID). Twenty five gave a precipitation line with human liver cytosol; 17 of the 25 also reacted with rat liver cytosol. Thirteen of the 25 sera were anti-HCV positive by second generation ELISA: anti-HCV positive patients were significantly older (p < 0.001) and tended to have less active disease. No difference in anti-LC1 titre or ID immunoreactivity was found between anti-LC1/anti-HCV positive and anti-LC1/anti-HCV negative cases. In Western blotting experiments, 14 of 24 ID positive sera recognised a 58 kD protein of the human cytosolic fraction and 11 gave a similar reactivity when tested with human microsomes, suggesting the presence of the LC1 target antigen also in the microsomal preparation. Western blotting reactivity was similar for both anti-HCV positive and negative sera. These data confirm the existence of the LC1 antigen-antibody system that partially overlaps with LKM1, and that it is an additional marker of juvenile autoimmune hepatitis type 2. It does not, however, discriminate between patients with and without HCV infection.

Full text

PDF
749

Images in this article

750Figure 1
on p.750
750Figure 2
on p.750
751Figure 3
on p.751
751Figure 4
on p.751
752Figure 5
on p.752

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abuaf N., Johanet C., Chretien P., Martini E., Soulier E., Laperche S., Homberg J. C. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology. 1992 Oct;16(4):892–898. doi: 10.1002/hep.1840160407. [DOI] [PubMed] [Google Scholar]
  2. Fusconi M., Baum H., Caselli A., Cassani F., Ballardini G., Lenzi M., Volta U., Zauli D., Bianchi F. B. Demonstration of peptide-specific and cross-reactive epitopes in proteins reacting with antimitochondrial antibodies of primary biliary cirrhosis. J Hepatol. 1992 May;15(1-2):162–169. doi: 10.1016/0168-8278(92)90030-s. [DOI] [PubMed] [Google Scholar]
  3. Fusconi M., Lenzi M., Ballardini G., Miniero R., Cassani F., Zauli D., Bianchi F. B. Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis. Lancet. 1990 Sep 29;336(8718):823–823. doi: 10.1016/0140-6736(90)93297-3. [DOI] [PubMed] [Google Scholar]
  4. Garson J. A., Lenzi M., Ring C., Cassani F., Ballardini G., Briggs M., Tedder R. S., Bianchi F. B. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol. 1991 Aug;34(4):223–226. doi: 10.1002/jmv.1890340405. [DOI] [PubMed] [Google Scholar]
  5. Garson J. A., Ring C. J., Tuke P. W. Improvement of HCV genome detection with "short" PCR products. Lancet. 1991 Dec 7;338(8780):1466–1467. doi: 10.1016/0140-6736(91)92775-w. [DOI] [PubMed] [Google Scholar]
  6. Lenzi M., Fusconi M., Selleri L., Caselli A., Cassani F., Bianchi F. B., Pisi E. Counterimmunoelectrophoresis (CIE) for the detection of anti-liver-kidney microsome (LKM) antibodies in the sera of patients with chronic liver disease. J Immunol Methods. 1988 Jul 22;111(2):253–259. doi: 10.1016/0022-1759(88)90134-2. [DOI] [PubMed] [Google Scholar]
  7. Lunel F., Abuaf N., Frangeul L., Grippon P., Perrin M., Le Coz Y., Valla D., Borotto E., Yamamoto A. M., Huraux J. M. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology. 1992 Sep;16(3):630–636. doi: 10.1002/hep.1840160304. [DOI] [PubMed] [Google Scholar]
  8. Martini E., Abuaf N., Cavalli F., Durand V., Johanet C., Homberg J. C. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology. 1988 Nov-Dec;8(6):1662–1666. doi: 10.1002/hep.1840080632. [DOI] [PubMed] [Google Scholar]
  9. Zanger U. M., Hauri H. P., Loeper J., Homberg J. C., Meyer U. A. Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8256–8260. doi: 10.1073/pnas.85.21.8256. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES